KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cme Group (CME) EPS (Basic): 2009-2025

Historic EPS (Basic) for Cme Group (CME) over the last 17 years, with Sep 2025 value amounting to $2.49.

  • Cme Group's EPS (Basic) fell 0.80% to $2.49 in Q3 2025 from the same period last year, while for Sep 2025 it was $10.33, marking a year-over-year increase of 8.39%. This contributed to the annual value of $9.69 for FY2024, which is 9.24% up from last year.
  • Per Cme Group's latest filing, its EPS (Basic) stood at $2.49 for Q3 2025, which was down 11.39% from $2.81 recorded in Q2 2025.
  • Cme Group's EPS (Basic)'s 5-year high stood at $2.81 during Q2 2025, with a 5-year trough of $1.42 in Q2 2021.
  • For the 3-year period, Cme Group's EPS (Basic) averaged around $2.41, with its median value being $2.43 (2024).
  • Per our database at Business Quant, Cme Group's EPS (Basic) surged by 125.22% in 2021 and then fell by 27.80% in 2022.
  • Quarterly analysis of 5 years shows Cme Group's EPS (Basic) stood at $1.69 in 2021, then climbed by 4.14% to $1.76 in 2022, then grew by 27.27% to $2.24 in 2023, then climbed by 7.14% to $2.40 in 2024, then decreased by 0.80% to $2.49 in 2025.
  • Its EPS (Basic) was $2.49 in Q3 2025, compared to $2.81 in Q2 2025 and $2.63 in Q1 2025.